Janine Kutzsche

909 total citations
46 papers, 671 citations indexed

About

Janine Kutzsche is a scholar working on Physiology, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Janine Kutzsche has authored 46 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Physiology, 17 papers in Molecular Biology and 14 papers in Computational Theory and Mathematics. Recurrent topics in Janine Kutzsche's work include Alzheimer's disease research and treatments (34 papers), Computational Drug Discovery Methods (14 papers) and Cholinesterase and Neurodegenerative Diseases (11 papers). Janine Kutzsche is often cited by papers focused on Alzheimer's disease research and treatments (34 papers), Computational Drug Discovery Methods (14 papers) and Cholinesterase and Neurodegenerative Diseases (11 papers). Janine Kutzsche collaborates with scholars based in Germany, United States and Netherlands. Janine Kutzsche's co-authors include Dieter Willbold, Antje Willuweit, Tamar Ziehm, Karl‐Josef Langen, Lothar Gremer, Markus Tusche, N. Jon Shah, Oleksandr Brener, Dagmar Jürgens and Luitgard Nagel‐Steger and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and The Journal of Cell Biology.

In The Last Decade

Janine Kutzsche

45 papers receiving 668 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janine Kutzsche Germany 16 419 380 137 123 77 46 671
Paolo De Bona Italy 11 504 1.2× 314 0.8× 121 0.9× 160 1.3× 59 0.8× 16 665
Claire J. Sarell United Kingdom 9 513 1.2× 325 0.9× 76 0.6× 57 0.5× 84 1.1× 12 665
Timothy Johanssen Australia 7 452 1.1× 235 0.6× 122 0.9× 109 0.9× 89 1.2× 8 585
Elke Reinartz Germany 7 653 1.6× 574 1.5× 140 1.0× 98 0.8× 40 0.5× 9 914
Frida Ekholm Pettersson Sweden 11 562 1.3× 391 1.0× 171 1.2× 152 1.2× 26 0.3× 15 830
Oleksandr Brener Germany 12 270 0.6× 269 0.7× 92 0.7× 72 0.6× 47 0.6× 16 432
C. Schenk Netherlands 2 609 1.5× 489 1.3× 131 1.0× 91 0.7× 38 0.5× 2 805
Isam Qahwash United States 8 458 1.1× 376 1.0× 94 0.7× 82 0.7× 39 0.5× 10 655
Ryan Limbocker United States 13 368 0.9× 390 1.0× 109 0.8× 82 0.7× 18 0.2× 26 724
Marino Convertino United States 16 353 0.8× 449 1.2× 185 1.4× 153 1.2× 38 0.5× 26 828

Countries citing papers authored by Janine Kutzsche

Since Specialization
Citations

This map shows the geographic impact of Janine Kutzsche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janine Kutzsche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janine Kutzsche more than expected).

Fields of papers citing papers by Janine Kutzsche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janine Kutzsche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janine Kutzsche. The network helps show where Janine Kutzsche may publish in the future.

Co-authorship network of co-authors of Janine Kutzsche

This figure shows the co-authorship network connecting the top 25 collaborators of Janine Kutzsche. A scholar is included among the top collaborators of Janine Kutzsche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janine Kutzsche. Janine Kutzsche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kutzsche, Janine, Markus Tusche, Michael T. Barbe, et al.. (2024). Elevated Aβ aggregates in feces from Alzheimer’s disease patients: a proof-of-concept study. Alzheimer s Research & Therapy. 16(1). 223–223. 1 indexed citations
2.
Kutzsche, Janine, Antje Willuweit, Olaf Kletke, et al.. (2023). An orally available Cav2.2 calcium channel inhibitor for the treatment of neuropathic pain. British Journal of Pharmacology. 181(12). 1734–1756. 7 indexed citations
3.
Langen, Karl‐Josef, et al.. (2023). Oral Treatment with d-RD2RD2 Impedes Early Disease Mechanisms in SOD1*G93A Transgenic Mice but Does Not Prolong Survival. Biomedicines. 11(4). 995–995. 2 indexed citations
4.
Willuweit, Antje, et al.. (2022). Development of an α-synuclein fibril and oligomer specific tracer for diagnosis of Parkinson's disease, dementia with Lewy bodies and multiple system atrophy. Neurochemistry International. 161. 105422–105422. 9 indexed citations
5.
Lohmann, Philipp, N. Jon Shah, Karl‐Josef Langen, et al.. (2021). A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model. Molecules. 26(6). 1590–1590. 7 indexed citations
6.
Shah, N. Jon, et al.. (2021). PEAβ Triggers Cognitive Decline and Amyloid Burden in a Novel Mouse Model of Alzheimer’s Disease. International Journal of Molecular Sciences. 22(13). 7062–7062. 4 indexed citations
7.
Bauer, Robert, N. Jon Shah, Karl‐Josef Langen, et al.. (2021). Sex-Related Motor Deficits in the Tau-P301L Mouse Model. Biomedicines. 9(9). 1160–1160. 6 indexed citations
8.
Santiago‐Schübel, Beatrix, et al.. (2020). Oral absorption enhancement of the amyloid-β oligomer eliminating compound RD2 by conjugation with folic acid. European Journal of Pharmaceutical Sciences. 156. 105581–105581. 4 indexed citations
9.
Tusche, Markus, Estíbaliz González de San Román, Silvia Sacchi, et al.. (2019). Metabolic resistance of the D-peptide RD2 developed for direct elimination of amyloid-β oligomers. Scientific Reports. 9(1). 5715–5715. 23 indexed citations
10.
Zafiu, Christian, Tamar Ziehm, Karl‐Josef Langen, et al.. (2018). Deceleration of the neurodegenerative phenotype in pyroglutamate-Aβ accumulating transgenic mice by oral treatment with the Aβ oligomer eliminating compound RD2. Neurobiology of Disease. 124. 36–45. 12 indexed citations
11.
Ziehm, Tamar, Markus Tusche, Oleksandr Brener, et al.. (2018). In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer’s Disease. Journal of Alzheimer s Disease. 64(3). 859–873. 10 indexed citations
12.
Zafiu, Christian, Sonja Hartwig, Stefan Lehr, et al.. (2018). Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology. Molecular Neurobiology. 56(3). 2211–2223. 31 indexed citations
13.
Ziehm, Tamar, Nan Jiang, Markus Tusche, et al.. (2017). Comparison of blood-brain barrier penetration efficiencies between linear and cyclic all-d-enantiomeric peptides developed for the treatment of Alzheimer's disease. European Journal of Pharmaceutical Sciences. 114. 93–102. 11 indexed citations
14.
15.
Groen, Thomas van, Oleksandr Brener, Lothar Gremer, et al.. (2017). The Aβ oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathology. Scientific Reports. 7(1). 16275–16275. 47 indexed citations
16.
Santiago‐Schübel, Beatrix, et al.. (2017). Surprisingly high stability of the Aβ oligomer eliminating all-d-enantiomeric peptide D3 in media simulating the route of orally administered drugs. European Journal of Pharmaceutical Sciences. 107. 203–207. 20 indexed citations
17.
Klein, Antonia, Markus Tusche, Christine Schlosser, et al.. (2016). Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity. PLoS ONE. 11(2). e0147470–e0147470. 13 indexed citations
18.
Jiang, Nan, Tamar Ziehm, Janine Kutzsche, et al.. (2016). Pharmacokinetic properties of tandem d-peptides designed for treatment of Alzheimer's disease. European Journal of Pharmaceutical Sciences. 89. 31–38. 23 indexed citations
19.
Jiang, Nan, Tamar Ziehm, Jörg Mauler, et al.. (2015). Preclinical Pharmacokinetic Studies of the Tritium Labelled D-Enantiomeric Peptide D3 Developed for the Treatment of Alzheimer´s Disease. PLoS ONE. 10(6). e0128553–e0128553. 39 indexed citations
20.
Jiang, Nan, Tamar Ziehm, Janine Kutzsche, et al.. (2015). Pharmacokinetic Properties of a Novel d-Peptide Developed to be Therapeutically Active Against Toxic β-Amyloid Oligomers. Pharmaceutical Research. 33(2). 328–336. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paolo De Bona Breakdown of academic impact, for papers by Claire J. Sarell Breakdown of academic impact, for papers by Timothy Johanssen Breakdown of academic impact, for papers by Elke Reinartz Breakdown of academic impact, for papers by Frida Ekholm Pettersson Breakdown of academic impact, for papers by Oleksandr Brener Breakdown of academic impact, for papers by C. Schenk Breakdown of academic impact, for papers by Isam Qahwash Breakdown of academic impact, for papers by Ryan Limbocker Breakdown of academic impact, for papers by Marino Convertino
Rankless by CCL
2026